Skip to Main Content
Table 1

Baseline characteristic of patients for the current study, as well as for the total 1980–2000 cohort

2000–2007
2000–2007
1980–2007
1980–2007
CharcotNeuropathic ulcerCharcotNeuropathic ulcer
n 70 66 117 109 
n (%) male 48 (68.6) 48 (72.7) 74 (63.2) 73 (67.0) 
n (%) type 2 diabetic 49 (70.0) 49 (74.2) 78 (66.7) 77 (70.6) 
Mean age ± SD (years) 57.4 ± 12.0 58.1 ± 12.2 58.1 ± 12.5 58.6 ± 12.5 
Mean diabetes duration ± SD (years) 16.1 ± 9.8 15.8 ± 9.6 16.1 ± 10.4 15.5 ± 10.4 
Renal dysfunction (n25* 28 49 43 
2000–2007
2000–2007
1980–2007
1980–2007
CharcotNeuropathic ulcerCharcotNeuropathic ulcer
n 70 66 117 109 
n (%) male 48 (68.6) 48 (72.7) 74 (63.2) 73 (67.0) 
n (%) type 2 diabetic 49 (70.0) 49 (74.2) 78 (66.7) 77 (70.6) 
Mean age ± SD (years) 57.4 ± 12.0 58.1 ± 12.2 58.1 ± 12.5 58.6 ± 12.5 
Mean diabetes duration ± SD (years) 16.1 ± 9.8 15.8 ± 9.6 16.1 ± 10.4 15.5 ± 10.4 
Renal dysfunction (n25* 28 49 43 

Renal dysfunction: serum creatinine concentration >130 μmol/l or estimated glomerular filtration rate <30 ml/min on two or more occasions.

*Missing data in two subjects.

†Missing data in four subjects.

‡Missing data in eight subjects.

Close Modal

or Create an Account

Close Modal
Close Modal